MedPath

SEATTLE CHILDREN'S HOSPITAL

SEATTLE CHILDREN'S HOSPITAL logo
🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website
http://www.seattlechildrens.org/research

Clinical Trials

199

Active:15
Completed:115

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:34
Phase 2:9
+3 more phases

Drug Approvals

1

FDA:1

Drug Approvals

Oxygen

Approval Date
Nov 6, 2023
FDA

Clinical Trials

Distribution across different clinical trial phases (181 trials with phase data)• Click on a phase to view related trials

Not Applicable
125 (69.1%)
Phase 1
34 (18.8%)
Phase 2
9 (5.0%)
Phase 3
6 (3.3%)
Phase 4
6 (3.3%)
Early Phase 1
1 (0.6%)

Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation With Parents

Not Applicable
Not yet recruiting
Conditions
Parents
Usability
First Posted Date
2025-06-15
Last Posted Date
2025-06-24
Lead Sponsor
Seattle Children's Hospital
Target Recruit Count
36
Registration Number
NCT07022392
Locations
🇺🇸

Seattle Children's Hospital, Seattle, Washington, United States

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

Not Applicable
Recruiting
Conditions
Diabetes Mellitus Type 2
First Posted Date
2025-04-20
Last Posted Date
2025-06-13
Lead Sponsor
Seattle Children's Hospital
Target Recruit Count
90
Registration Number
NCT06936670
Locations
🇺🇸

Seattle Children's Hospital, Seattle, Washington, United States

🇺🇸

University of Washington Medicine Diabetes Institute, Seattle, Washington, United States

Using Ecological Momentary Assessment to Develop an Adaptive Psychological Intervention for Young Adults With Chronic Pain

Recruiting
Conditions
Chronic Pain
First Posted Date
2025-04-17
Last Posted Date
2025-04-27
Lead Sponsor
Seattle Children's Hospital
Target Recruit Count
50
Registration Number
NCT06932432
Locations
🇺🇸

Seattle Children's Hospital, Seattle, Washington, United States

Evaluating Huddles As a Novel Approach to Improving Concussion Safety

Not Applicable
Not yet recruiting
Conditions
Mild Traumatic Brain Injury
First Posted Date
2025-03-07
Last Posted Date
2025-03-07
Lead Sponsor
Seattle Children's Hospital
Target Recruit Count
2000
Registration Number
NCT06864611

Pilot Trial of the RUBI Program for Autistic Adults

Not Applicable
Recruiting
Conditions
Autism Spectrum Disorder
Behavior
Parenting
First Posted Date
2024-09-12
Last Posted Date
2024-09-12
Lead Sponsor
Seattle Children's Hospital
Target Recruit Count
80
Registration Number
NCT06593613
Locations
🇺🇸

Els for Autism Foundation, Jupiter, Florida, United States

🇺🇸

A.J. Drexel Autism Institute, Philadelphia, Pennsylvania, United States

🇺🇸

Seattle Children's Autism Center, Seattle, Washington, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 40
  • Next

News

Blinatumomab Combination Therapy Wins Prestigious Trial of the Year Award for Pediatric Leukemia Breakthrough

The Children's Oncology Group AALL1731 trial received the David Sackett Trial of the Year Award for demonstrating that adding blinatumomab to chemotherapy reduces relapse risk by about two-thirds in children with B-cell acute lymphoblastic leukemia.

B7-H3 CAR T-Cell Therapy Shows Promise in Diffuse Intrinsic Pontine Glioma

A phase I clinical trial demonstrates the feasibility and tolerability of repeated intraventricular B7-H3 CAR T-cell infusions in children with DIPG.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.